Search

Your search keyword '"Guaraldi, G."' showing total 1,282 results

Search Constraints

Start Over You searched for: Author "Guaraldi, G." Remove constraint Author: "Guaraldi, G."
1,282 results on '"Guaraldi, G."'

Search Results

2. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

3. Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort

4. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

5. Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort

6. SARS‐CoV‐2 testing, positivity, and factors associated with COVID‐19 among people with HIV across Europe in the multinational EuroSIDA cohort.

13. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

14. A79 THE RELATIONSHIP BETWEEN VISCERAL ADIPOSITY AND NONALCOHOLIC FATTY LIVER DISEASE DIAGNOSED BY CONTROLLED ATTENUATION PARAMETER IN PEOPLE WITH HIV: A PILOT STUDY

15. Pillars of long-term antiretroviral therapy success

16. Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda

17. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

18. Hepatitis delta virus (hdv) replication through hbv integrants in hcc recurrence after liver transplantation.

20. High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid

21. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

22. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

23. Determinants of loss to care and risk of clinical progression in PLWH who are re-engaged in care after a temporary loss

24. Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort

28. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

29. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

31. Non-alcoholic to metabolic associated fatty liver disease: Cardiovascular implications of a change in terminology in patients living with HIV

32. Evaluation of HIV transmission clusters among natives and foreigners living in Italy

33. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

34. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

35. Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort

36. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

37. 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

38. Hypokalemia in Patients with COVID-19

39. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

40. Evaluation of HIV transmission clusters among natives and foreigners living in Italy

41. Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort

42. Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021

43. Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia, A double-blind, randomised, placebo-controlled trial

45. Cost of noninfectious comorbidities in patients with HIV

49. First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy

Catalog

Books, media, physical & digital resources